A limited number of studies in Parkinson's Disease (PD) suggest a disturbance of recognition of facial emotion expressions. In particular, disgust recognition impairment has been reported in unmedicated and medicated PD patients. However, the results are rather inconclusive in the definition of the degree and the selectivity of emotion recognition impairment, and an associated impairment of almost all basic facial emotions in PD is also described. Few studies have investigated the relationship with neuropsychiatric and neuropsychological symptoms with mainly negative results. This inconsistency may be due to many different problems, such as emotion assessment, perception deficit, cognitive impairment, behavioral symptoms, illness severity and antiparkinsonian therapy. Here we review the clinical characteristics and neural structures involved in the recognition of specific facial emotion expressions, and the plausible role of dopamine transmission and dopamine replacement therapy in these processes. It is clear that future studies should be directed to clarify all these issues.

Assogna, F., Pontieri, F., Caltagirone, C., Spalletta, G. (2008). The recognition of facial emotion expressions in Parkinson's disease. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 18(11), 835-848 [10.1016/j.euroneuro.2008.07.004].

The recognition of facial emotion expressions in Parkinson's disease

CALTAGIRONE, CARLO;
2008-11-01

Abstract

A limited number of studies in Parkinson's Disease (PD) suggest a disturbance of recognition of facial emotion expressions. In particular, disgust recognition impairment has been reported in unmedicated and medicated PD patients. However, the results are rather inconclusive in the definition of the degree and the selectivity of emotion recognition impairment, and an associated impairment of almost all basic facial emotions in PD is also described. Few studies have investigated the relationship with neuropsychiatric and neuropsychological symptoms with mainly negative results. This inconsistency may be due to many different problems, such as emotion assessment, perception deficit, cognitive impairment, behavioral symptoms, illness severity and antiparkinsonian therapy. Here we review the clinical characteristics and neural structures involved in the recognition of specific facial emotion expressions, and the plausible role of dopamine transmission and dopamine replacement therapy in these processes. It is clear that future studies should be directed to clarify all these issues.
nov-2008
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/26 - NEUROLOGIA
English
Con Impact Factor ISI
Emotions; Facial Expression; Recognition (Psychology); Parkinson Disease; Humans; Cognition Disorders
Assogna, F., Pontieri, F., Caltagirone, C., Spalletta, G. (2008). The recognition of facial emotion expressions in Parkinson's disease. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 18(11), 835-848 [10.1016/j.euroneuro.2008.07.004].
Assogna, F; Pontieri, F; Caltagirone, C; Spalletta, G
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/32516
Citazioni
  • ???jsp.display-item.citation.pmc??? 31
  • Scopus 96
  • ???jsp.display-item.citation.isi??? 90
social impact